This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beardmore, V. A.
Right arrow Articles by Arthur, J. S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beardmore, V. A.
Right arrow Articles by Arthur, J. S. C.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2005, p. 10454-10464, Vol. 25, No. 23
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.23.10454-10464.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Generation and Characterization of p38ß (MAPK11) Gene-Targeted Mice

Victoria A. Beardmore,1 Heather J. Hinton,2 Christina Eftychi,4 Maria Apostolaki,4 Maria Armaka,4 Joanne Darragh,1 Joanne McIlrath,1 Julia M. Carr,1 Laura J. Armit,3 Carol Clacher,3 Loraine Malone,3 George Kollias,4 and J. Simon C. Arthur1*

MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, United Kingdom,1 Division of Immunology and Cell Biology, School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, United Kingdom,2 School of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, United Kingdom,3 Institute of Immunology, Biomedical Sciences Research Centre Al. Fleming, Vari 162-72, Greece4

Received 27 July 2005/ Accepted 23 August 2005

p38 mitogen-activated protein kinases (MAPKs) are activated primarily in response to inflammatory cytokines and cellular stress, and inhibitors which target the p38{alpha} and p38ß MAPKs have shown potential for the treatment of inflammatory disease. Here we report the generation and initial characterization of a knockout of the p38ß (MAPK11) gene. p38ß–/– mice were viable and exhibited no apparent health problems. The expression and activation of p38{alpha}, ERK1/2, and JNK in response to cellular stress was normal in embryonic fibroblasts from p38ß–/– mice, as was the activation of p38-activated kinases MAPKAP-K2 and MSK1. The transcription of p38-dependent immediate-early genes was also not affected by the knockout of p38ß, suggesting that p38{alpha} is the predominant isoform involved in these processes. The p38ß–/– mice also showed normal T-cell development. Lipopolysaccharide-induced cytokine production was also normal in the p38ß–/– mice. As p38 is activated by tumor necrosis factor, the p38ß–/– mice were crossed onto a TNF{Delta}ARE mouse line. These mice overexpress tumor necrosis factor, which results in development symptoms similar to rheumatoid arthritis and inflammatory bowel disease. The progression of these diseases was not however moderated by knockout of p38ß. Together these results suggest that p38{alpha}, and not p38ß, is the major p38 isoform involved in the immune response and that it would not be necessary to retain activity against p38ß during the development of p38 inhibitors.


* Corresponding author. Mailing address: MRC Protein Phosphorylation Unit, Faculty of Life Sciences, University of Dundee, Dundee, Scotland DD1 5EH, United Kingdom. Phone: (0)1382 344003. Fax: (0)1382 223778. E-mail: j.s.c.Arthur{at}dundee.ac.uk.


Molecular and Cellular Biology, December 2005, p. 10454-10464, Vol. 25, No. 23
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.23.10454-10464.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Bohm, C., Hayer, S., Kilian, A., Zaiss, M. M., Finger, S., Hess, A., Engelke, K., Kollias, G., Kronke, G., Zwerina, J., Schett, G., David, J.-P. (2009). The {alpha}-Isoform of p38 MAPK Specifically Regulates Arthritic Bone Loss. J. Immunol. 183: 5938-5947 [Abstract] [Full Text]  
  • Geest, C. R., Coffer, P. J. (2009). MAPK signaling pathways in the regulation of hematopoiesis. J. Leukoc. Biol. 86: 237-250 [Abstract] [Full Text]  
  • Zhao, C., Ivanov, I., Dougherty, E. R., Hartman, T. J., Lanza, E., Bobe, G., Colburn, N. H., Lupton, J. R., Davidson, L. A., Chapkin, R. S. (2009). Noninvasive Detection of Candidate Molecular Biomarkers in Subjects with a History of Insulin Resistance and Colorectal Adenomas. Cancer Prevention Research 2: 590-597 [Abstract] [Full Text]  
  • Kwong, J., Hong, L., Liao, R., Deng, Q., Han, J., Sun, P. (2009). p38{alpha} and p38{gamma} Mediate Oncogenic ras-induced Senescence through Differential Mechanisms. J. Biol. Chem. 284: 11237-11246 [Abstract] [Full Text]  
  • Hill, R. J., Dabbagh, K., Phippard, D., Li, C., Suttmann, R. T., Welch, M., Papp, E., Song, K. W., Chang, K.-c., Leaffer, D., Kim, Y.-N., Roberts, R. T., Zabka, T. S., Aud, D., Porto, J. D., Manning, A. M., Peng, S. L., Goldstein, D. M., Wong, B. R. (2008). Pamapimod, a Novel p38 Mitogen-Activated Protein Kinase Inhibitor: Preclinical Analysis of Efficacy and Selectivity. J. Pharmacol. Exp. Ther. 327: 610-619 [Abstract] [Full Text]  
  • Schett, G, Zwerina, J, Firestein, G (2008). The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis 67: 909-916 [Abstract] [Full Text]  
  • Polzer, K, Soleiman, A, Baum, W, Axmann, R, Distler, J, Redlich, K, Kilian, A, Kronke, G, Schett, G, Zwerina, J (2008). Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPK{alpha}. Ann Rheum Dis 67: 602-608 [Abstract] [Full Text]  
  • O'Keefe, S. J., Mudgett, J. S., Cupo, S., Parsons, J. N., Chartrain, N. A., Fitzgerald, C., Chen, S.-L., Lowitz, K., Rasa, C., Visco, D., Luell, S., Carballo-Jane, E., Owens, K., Zaller, D. M. (2007). Chemical Genetics Define the Roles of p38{alpha} and p38 in Acute and Chronic Inflammation. J. Biol. Chem. 282: 34663-34671 [Abstract] [Full Text]  
  • Schindler, J.F., Monahan, J.B., Smith, W.G. (2007). p38 Pathway Kinases as Anti-inflammatory Drug Targets. JDR 86: 800-811 [Abstract] [Full Text]  
  • White, A., Pargellis, C. A., Studts, J. M., Werneburg, B. G., Farmer, B. T. II (2007). Molecular basis of MAPK-activated protein kinase 2:p38 assembly. Proc. Natl. Acad. Sci. USA 104: 6353-6358 [Abstract] [Full Text]  
  • Askari, N., Diskin, R., Avitzour, M., Capone, R., Livnah, O., Engelberg, D. (2007). Hyperactive Variants of p38{alpha} Induce, whereas Hyperactive Variants of p38{gamma} Suppress, Activating Protein 1-mediated Transcription. J. Biol. Chem. 282: 91-99 [Abstract] [Full Text]  
  • Ronkina, N., Kotlyarov, A., Dittrich-Breiholz, O., Kracht, M., Hitti, E., Milarski, K., Askew, R., Marusic, S., Lin, L.-L., Gaestel, M., Telliez, J.-B. (2007). The Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinases MK2 and MK3 Cooperate in Stimulation of Tumor Necrosis Factor Biosynthesis and Stabilization of p38 MAPK. Mol. Cell. Biol. 27: 170-181 [Abstract] [Full Text]  
  • Olson, C. M., Hedrick, M. N., Izadi, H., Bates, T. C., Olivera, E. R., Anguita, J. (2007). p38 Mitogen-Activated Protein Kinase Controls NF-{kappa}B Transcriptional Activation and Tumor Necrosis Factor Alpha Production through RelA Phosphorylation Mediated by Mitogen- and Stress-Activated Protein Kinase 1 in Response to Borrelia burgdorferi Antigens. Infect. Immun. 75: 270-277 [Abstract] [Full Text]  
  • Bennett, B. L. (2006). c-Jun N-terminal kinase-dependent mechanisms in respiratory disease.. Eur Respir J 28: 651-661 [Abstract] [Full Text]  
  • Silva, G., Cunha, A., Gregoire, I. P., Seldon, M. P., Soares, M. P. (2006). The Antiapoptotic Effect of Heme Oxygenase-1 in Endothelial Cells Involves the Degradation of p38{alpha} MAPK Isoform. J. Immunol. 177: 1894-1903 [Abstract] [Full Text]